Ryjunea
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ryjunea, covering 2025-09-11 to 2026-07-22. Get the full timeline:
Most recent: EMA Authorised: Ryjunea (atropine sulfate) — Santen Oy
2 regulatory and trial events tracked for Ryjunea, covering 2025-09-11 to 2026-07-22. Get the full timeline:
Most recent: EMA Authorised: Ryjunea (atropine sulfate) — Santen Oy